The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells

The only currently available approach to early efficacy testing of tuberculosis (TB) vaccine candidates is in vivo preclinical challenge models. These typically include mice, guinea pigs and non-human primates (NHPs), which must be exposed to virulent M.tb in a ‘challenge’ experiment following vacci...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Tanner, R, Hoogkamer, E, Bitencourt, J, White, A, Boot, C, Sombroek, CC, Harris, SA, O'Shea, MK, Wright, D, Wittenberg, R, Sarfas, C, Satti, I, Verreck, FAW, Sharpe, SA, Fletcher, HA, McShane, H
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	F1000Research 2021

Gelijkaardige items

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 1; peer review: 2 approved]
door: Rachel Tanner, et al.
Gepubliceerd in: (2021-03-01)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 2; peer review: 2 approved]
door: Rachel Tanner, et al.
Gepubliceerd in: (2021-09-01)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
door: Tanner, R, et al.
Gepubliceerd in: (2021)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
door: Rachel Tanner, et al.
Gepubliceerd in: (2021-01-01)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
door: Pepponi, I, et al.
Gepubliceerd in: (2017)

The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
door: Brennan, M, et al.
Gepubliceerd in: (2017)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
door: Tanner, R, et al.
Gepubliceerd in: (2021)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
door: Tanner, R, et al.
Gepubliceerd in: (2020)

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
door: Rachel Tanner, et al.
Gepubliceerd in: (2020-01-01)

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
door: Painter, H, et al.
Gepubliceerd in: (2024)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
door: Mcshane, H, et al.
Gepubliceerd in: (2017)

Distinct transcriptional and anti-mycobacterial profiles of peripheral blood monocytes dependent on the ratio of monocytes: lymphocytes
door: Naranbhai, V, et al.
Gepubliceerd in: (2015)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
door: Harris, S, et al.
Gepubliceerd in: (2017)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
door: O'Shea, M, et al.
Gepubliceerd in: (2018)

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model
door: Matsumiya, M, et al.
Gepubliceerd in: (2014)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
door: Tanner, R, et al.
Gepubliceerd in: (2017)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
door: Marsay, L, et al.
Gepubliceerd in: (2013)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
door: Marsay, L, et al.
Gepubliceerd in: (2013)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
door: Matthew K. O’Shea, et al.
Gepubliceerd in: (2018-09-01)

Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients
door: Ongarj, J, et al.
Gepubliceerd in: (2024)

Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes
door: Vivek Naranbhai, et al.
Gepubliceerd in: (2015-11-01)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
door: Painter, H, et al.
Gepubliceerd in: (2024)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
door: Alvarez, MPP, et al.
Gepubliceerd in: (2024)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
door: Hannah Painter, et al.
Gepubliceerd in: (2024-02-01)

Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection
door: Matthew K. O'Shea, et al.
Gepubliceerd in: (2018-12-01)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
door: McNeill, E, et al.
Gepubliceerd in: (2018)

Human hookworm infection enhances mycobacterial growth inhibition and associates with reduced risk of tuberculosis infection
door: O'Shea, M, et al.
Gepubliceerd in: (2018)

Induction of functional specific antibodies, IgG-secreting plasmablasts and memory B cells following BCG vaccination
door: Bitencourt, J, et al.
Gepubliceerd in: (2021)

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates
door: Peralta-Álvarez, MP, et al.
Gepubliceerd in: (2024)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
door: Eileen McNeill, et al.
Gepubliceerd in: (2018-12-01)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
door: Marco Polo Peralta Alvarez, et al.
Gepubliceerd in: (2024-05-01)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
door: Fletcher, H, et al.
Gepubliceerd in: (2013)

The characterisation of mycobacterial control profiles and underlying immune signatures in patients with latent tuberculosis infection and active disease
door: O'Shea, M
Gepubliceerd in: (2016)

Evaluating the effect of BCG vaccination on a whole-blood mycobacterial growth inhibition assay (BACTEC MGIT)
door: Tanner, R, et al.
Gepubliceerd in: (2011)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
door: Meyer, J, et al.
Gepubliceerd in: (2013)

Quantitative Rapid Test for Detection and Monitoring of Active Pulmonary Tuberculosis in Nonhuman Primates
door: Zijie Zhou, et al.
Gepubliceerd in: (2021-12-01)

A review of clinical models for the evaluation of human TB vaccines.
door: O'Shea, M, et al.
Gepubliceerd in: (2016)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
door: Painter, H, et al.
Gepubliceerd in: (2020)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
door: Matsumiya, M, et al.
Gepubliceerd in: (2014)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
door: Meyer, J, et al.
Gepubliceerd in: (2013)